Matches in SemOpenAlex for { <https://semopenalex.org/work/W2531856938> ?p ?o ?g. }
- W2531856938 endingPage "888" @default.
- W2531856938 startingPage "882" @default.
- W2531856938 abstract "Ruxolitinib is an oral Janus-activated kinase 1 (JAK1)/JAK2 inhibitor approved for the treatment of patients with myelofibrosis based on the results of two randomized clinical trials. However, discordant indications were provided by regulatory agencies and scientific societies for selecting the most appropriate candidates to this drug. The European LeukemiaNet and the Italian Society of Hematology shared the aim of building evidence-based recommendations for the use of ruxolitinib according to the GRADE methodology. Eighteen patient-intervention-comparator-outcome profiles were listed, each of them comparing ruxolitinib to other therapies with the aim of improving one of the three clinical outcomes: (a) splenomegaly, (b) disease-related symptoms, and (c) survival. Ruxolitinib was strongly recommended for improving symptomatic or severe (>15 cm below the costal margin) splenomegaly in patients with an International Prognostic Scoring System (IPSS)/dynamic IPSS risk intermediate 2 or high. Ruxolitinib was also strongly recommended for improving systemic symptoms in patients with an MPN10 score >44, refractory severe itching, unintended weight loss not attributable to other causes or unexplained fever. Because of weak evidence, the panel does not recommend ruxolitinib therapy for improving survival. Also, the recommendations given above do not necessarily apply to patients who are candidates for allogeneic stem cell transplant." @default.
- W2531856938 created "2016-10-21" @default.
- W2531856938 creator A5001646221 @default.
- W2531856938 creator A5006360930 @default.
- W2531856938 creator A5008609620 @default.
- W2531856938 creator A5009381933 @default.
- W2531856938 creator A5012374853 @default.
- W2531856938 creator A5018111458 @default.
- W2531856938 creator A5046772202 @default.
- W2531856938 creator A5046827092 @default.
- W2531856938 creator A5059159915 @default.
- W2531856938 creator A5069072959 @default.
- W2531856938 creator A5072839097 @default.
- W2531856938 creator A5079400134 @default.
- W2531856938 creator A5089433535 @default.
- W2531856938 date "2016-10-14" @default.
- W2531856938 modified "2023-10-14" @default.
- W2531856938 title "Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations" @default.
- W2531856938 cites W1247968195 @default.
- W2531856938 cites W1812179083 @default.
- W2531856938 cites W1861743845 @default.
- W2531856938 cites W1976651396 @default.
- W2531856938 cites W1986442976 @default.
- W2531856938 cites W1987159900 @default.
- W2531856938 cites W1991495650 @default.
- W2531856938 cites W1997682711 @default.
- W2531856938 cites W2008799537 @default.
- W2531856938 cites W2010298229 @default.
- W2531856938 cites W2022290794 @default.
- W2531856938 cites W2043993681 @default.
- W2531856938 cites W2062126843 @default.
- W2531856938 cites W2078826725 @default.
- W2531856938 cites W2083073031 @default.
- W2531856938 cites W2086420219 @default.
- W2531856938 cites W2105235256 @default.
- W2531856938 cites W2108052450 @default.
- W2531856938 cites W2110811050 @default.
- W2531856938 cites W2112000215 @default.
- W2531856938 cites W2115351357 @default.
- W2531856938 cites W2118152564 @default.
- W2531856938 cites W2121743767 @default.
- W2531856938 cites W2123633897 @default.
- W2531856938 cites W2126532431 @default.
- W2531856938 cites W2127559749 @default.
- W2531856938 cites W2129475142 @default.
- W2531856938 cites W2143057570 @default.
- W2531856938 cites W2147666686 @default.
- W2531856938 cites W2157066112 @default.
- W2531856938 cites W2170961171 @default.
- W2531856938 cites W2218840816 @default.
- W2531856938 cites W2254184051 @default.
- W2531856938 cites W2294247703 @default.
- W2531856938 cites W2345645288 @default.
- W2531856938 cites W2405712018 @default.
- W2531856938 cites W2418937816 @default.
- W2531856938 cites W2567309072 @default.
- W2531856938 cites W2593028116 @default.
- W2531856938 cites W2977273311 @default.
- W2531856938 doi "https://doi.org/10.1038/leu.2016.283" @default.
- W2531856938 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27740634" @default.
- W2531856938 hasPublicationYear "2016" @default.
- W2531856938 type Work @default.
- W2531856938 sameAs 2531856938 @default.
- W2531856938 citedByCount "37" @default.
- W2531856938 countsByYear W25318569382017 @default.
- W2531856938 countsByYear W25318569382018 @default.
- W2531856938 countsByYear W25318569382019 @default.
- W2531856938 countsByYear W25318569382020 @default.
- W2531856938 countsByYear W25318569382021 @default.
- W2531856938 countsByYear W25318569382022 @default.
- W2531856938 countsByYear W25318569382023 @default.
- W2531856938 crossrefType "journal-article" @default.
- W2531856938 hasAuthorship W2531856938A5001646221 @default.
- W2531856938 hasAuthorship W2531856938A5006360930 @default.
- W2531856938 hasAuthorship W2531856938A5008609620 @default.
- W2531856938 hasAuthorship W2531856938A5009381933 @default.
- W2531856938 hasAuthorship W2531856938A5012374853 @default.
- W2531856938 hasAuthorship W2531856938A5018111458 @default.
- W2531856938 hasAuthorship W2531856938A5046772202 @default.
- W2531856938 hasAuthorship W2531856938A5046827092 @default.
- W2531856938 hasAuthorship W2531856938A5059159915 @default.
- W2531856938 hasAuthorship W2531856938A5069072959 @default.
- W2531856938 hasAuthorship W2531856938A5072839097 @default.
- W2531856938 hasAuthorship W2531856938A5079400134 @default.
- W2531856938 hasAuthorship W2531856938A5089433535 @default.
- W2531856938 hasBestOaLocation W25318569382 @default.
- W2531856938 hasConcept C126322002 @default.
- W2531856938 hasConcept C141071460 @default.
- W2531856938 hasConcept C143998085 @default.
- W2531856938 hasConcept C194409129 @default.
- W2531856938 hasConcept C2776112149 @default.
- W2531856938 hasConcept C2780007613 @default.
- W2531856938 hasConcept C2780076729 @default.
- W2531856938 hasConcept C2780240888 @default.
- W2531856938 hasConcept C2780817109 @default.
- W2531856938 hasConcept C535046627 @default.
- W2531856938 hasConcept C71924100 @default.
- W2531856938 hasConceptScore W2531856938C126322002 @default.